Advertisement

Percutaneous Transluminal Coronary Angioplasty During Acute Myocardial Infarction

  • Michael S. Remetz
    Correspondence
    Corresponding Author: Section of Cardiology, 3 FMP, Yale University School of Medicine, 333 Cedar Street, P.O. Box 3333, New Haven, CT 06510
    Affiliations
    Assistant Professor of Medicine, Yale University School of Medicine; and Attending Physician, Yale-New Haven Hospital, New Haven, and West Haven VA Medical Center, West Haven, Connecticut
    Search for articles by this author
  • Michael W. Cleman
    Affiliations
    Associate Professor of Medicine; Director, Cardiac Catheterization Laboratory and PTCA Service, Yale University School of Medicine; and Attending Physician, Yale-New Haven Hospital, New Haven, and West Haven VA Medicial Center, West Haven, Connecticut
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      With the recognition of the importance of early restoration of coronary blood flow to limit the size of myocardial infarction, recent investigation has evaluated PTCA as a means of reestablishing blood flow in acutely occluded coronary arteries. Current research is evaluating the effectiveness of PTCA in reducing post-infarction ischemic episodes, improving left ventricular function, and reducing early mortality.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anderson J.L.
        • Marshall H.W.
        • Askins J.C.
        • et al.
        A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.
        Circulation. 1984; 70: 606
        • Anderson J.L.
        • Marshall H.W.
        • Bray B.E.
        • et al.
        A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction.
        N Engl J Med. 1983; 308: 1312
        • Berg R.
        • Seiinger S.L.
        • Leonard J.J.
        • et al.
        Immediate coronary artery bypass for acute evolving myocardial infarction.
        J Thorac Cardiovasc Surg. 1981; 81: 493
        • Bresnahan D.R.
        • Davis J.L.
        • Holmes D.R.
        • Smith H.C.
        Angiographic occurrence and clinical correlates of intraluminal coronary artery thrombus: Role of unstable angina.
        J Am Coll Cardiol. 1985; 6: 285
        • Brown B.G.
        • Gallery C.A.
        • Badger R.S.
        • et al.
        Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: Quantitative angiographic observations.
        Circulation. 1986; 73: 653
        • Bush L.
        • Buja M.
        • Samowitz W.
        • et al.
        Recovery of left ventricular segmental function after long-term reper-fusion following temporary coronary occlusion in conscious dogs.
        Circ Res. 1983; 53: 248
        • Capone G.
        • Wolf N.M.
        • Meyer B.
        • Meister S.G.
        Frequency of intracoronary filling defects by angiography in angina pectoris at rest.
        Am J Cardiol. 1985; 56: 403
        • Chesebro J.H.
        • Knatternd G.
        • Roberts R.
        • et al.
        Throm-bolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase.
        Circulation. 1987; 76: 142
        • Colavita P.G.
        • Ideker R.E.
        • Reimer K.A.
        • et al.
        The spectrum of pathology associated with percutaneous transluminal coronary angioplasty during acute myocardial infarction.
        J Am Coll Cardiol. 1986; 8: 855
        • Collen D.
        Molecular mechanism of action of newer thrombolytic agents.
        J Am Coll Cardiol. 1987; 10: 11B
        • Collen D.
        • Stassen J.
        • Stump D.C.
        • et al.
        Synergism of thrombolytic agents in vivo.
        Circulation. 1986; 74: 838
        • Collen D.
        • Stump D.C.
        • Van de Werf F.
        Coronary throm-bolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents.
        Am Heart J. 1986; 112: 1083
        • Davies M.J.
        • Thomas A.
        Thrombosis and acute coronary-artery lesions in sudden ischemic death.
        N Engl J Med. 1984; 310: 11337
        • DeWood M.A.
        • Heit J.
        • Spores J.
        • et al.
        Anterior transmural myocardial infarction: Effects of surgical coronary reperfusion on global and regional left ventricular function.
        J Am Coll Cardiol. 1983; 1: 1223
        • DeWood M.A.
        • Spores J.
        • Notske R.N.
        • et al.
        Medical and surgical management of mycocardial infarction.
        Am J Cardiol. 1979; 44: 1356
        • DeWood M.A.
        • Spores J.
        • Notske R.N.
        • et al.
        Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.
        N Engl J Med. 1980; 303: 897
        • DeWood M.A.
        • Stifter W.F.
        • Simpson C.S.
        • et al.
        Coronary arteriographie findings soon after non-Q-wave myocardial infarction.
        N Engl J Med. 1986; 315: 417
        • Duber C.
        • Jungbluth A.
        • Rumpelt H.J.
        • et al.
        Morphology of the coronary arteries after combined thrombolysis and percutaneous transluminal coronary angioplasty for acute myocardial infarction.
        Am J Cardiol. 1986; 58: 698
        • Falk E.
        Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.
        Circulation. 1985; 71: 699
        • Friesinger C.G.
        Prognosis of atherosclerotic coronary heart disease.
        in: Hirst J.W. The Heart. Edition 6. McGraw-Hill, New York1986: 924
        • Fung A.Y.
        • Lai P.
        • Juni J.E.
        • et al.
        Prevention of subsequent exercise-induced periinfarct ischemia by emergency coronary angioplasty in acute myocardial infarction: Comparison with intracoronary streptokinase.
        J Am Coll Cardiol. 1986; 8: 496
        • Fung A.Y.
        • Lai P.
        • Topol E.J.
        • et al.
        Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction.
        Am J Cardiol. 1986; 58: 686
        • Ganz W.
        • Geft I.
        • Shah P.K.
        • et al.
        Intravenous strepto-kinase in evolving acute myocardial infarction.
        Am J Cardiol. 1984; 53: 1209
        • Ganz W.
        • Ninomiya K.
        • Hashida J.
        • et al.
        Intracoronary thrombolysis in acute myocardial infarction: Experimental background and clinical experience.
        Am Heart J. 1981; 102: 1145
        • Gold H.K.
        • Johns J.A.
        • Leinbach R.C.
        • et al.
        A randomized, blinded placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.
        Circulation. 1987; 75: 1192
        • Gold H.K.
        • Leinbach R.C.
        • Garabedian H.D.
        • et al.
        Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: Prevention by a maintenance infusion.
        Circulation. 1986; 73: 347
        • Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
        Lancet. 1986; 1: 397
        • Guerci A.D.
        • Gerstenblith G.
        • Brinker J.A.
        • et al.
        A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty.
        N Engl J Med. 1987; 317: 1613
        • Gurewich V.
        • Pannell R.
        A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: Demonstration of synergism and of different thresholds of nonselectivity.
        Thromb Res. 1986; 44: 217
        • Harrison D.G.
        • Ferguson D.W.
        • Collins S.M.
        • et al.
        Rethrombosis after reperfusion with streptokinase: Importance of geometry of residual lesions.
        Circulation. 1984; 69: 991
        • Hartzler G.O.
        • Rutherford B.D.
        • McConahay D.R.
        Percutaneous transluminal coronary angioplasty: Application for acute nyocardial infarction.
        Am J Cardiol. 1984; 53: 117C
        • ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM)
        N Engl J Med. 1986; 314: 1465
        • Jennings R.
        • Reimer K.
        Factors involved in salvaging ischemic myocardium: Effect of reperfusion of arterial blood.
        Circulation. 1983; 68: 1-25
        • Kennedy J.W.
        • Ritchie J.L.
        • Davis K.B.
        • et al.
        The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: A 12-month follow-up report.
        N Engl J Med. 1985; 312: 1073
        • Kennedy J.W.
        • Ritchie J.L.
        • Davis K.B.
        • et al.
        Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.
        N Engl J Med. 1983; 309: 1477
        • Khaja F.
        • Walton J.A.
        • Brymer J.F.
        • et al.
        Intracoronary fibrinolytic therapy in acute myocardial infarction.
        N Engl J Med. 1983; 308: 1305
        • Kloner R.
        • Rude R.
        • Carlson N.
        • et al.
        Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first?.
        Circulation. 1980; 62: 945
        • Lai P.
        • O’Neill W.
        • Auth D.
        • et al.
        Nonsurgical human coronary endarterectomy: Use of a mechanical rotary catheter.
        Circulation. 1985; 72: 111-371
        • Leiboff R.
        • Katz R.J.
        • Wasserman A.G.
        • et al.
        A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction.
        Am J Cardiol. 1984; 53: 404
        • Mcintosh H.D.
        • Buccino R.A.
        Emergency coronary artery revascularization of patients with acute myocardial infarction: You can but should you? (editorial).
        Circulation. 1979; 60: 247
        • Miller H.I.
        • Almagor Y.
        • Keren G.
        • et al.
        Early intervention in acute myocardial infarction: Significance for myocardial salvage of immediate intravenous streptokinase therapy followed by coronary angioplasty.
        J Am Coll Cardiol. 1987; 9: 608
        • O’Neill W.
        • Timmis G.C.
        • Bourdillon P.D.
        • et al.
        A pro-spective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction.
        N Engl J Med. 1986; 314: 812
        • Papapietro S.E.
        • MacLean W.A.H.
        • Stanley A.W.H.
        • et al.
        Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction.
        Am J Cardiol. 1985; 55: 48
        • Passamani E.
        • Hodges M.
        • Herman M.
        • et al.
        The throm-bolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.
        J Am Coll Cardiol. 1987; 10: 51B
        • Phillips S.J.
        • Kongtahworn C.
        • Zeff R.H.
        • et al.
        Emergency coronary artery revascularization: A possible therapy for acute myocardial infarction.
        Circulation. 1979; 60: 241
        • Prida X.E.
        • Holland J.P.
        • Feldman R.L.
        • et al.
        Percutaneous transluminal coronary angioplasty in evolving acute myocardial infarction.
        Am J Cardiol. 1986; 57: 1069
        • Raizner A.E.
        • Tortoledo F.A.
        • Verani M.S.
        • et al.
        Intra-coronary thrombolytic therapy in acute myocardial infarction: A prospective, randomized, controlled trial.
        Am J Cardiol. 1985; 55: 301
        • Reduto L.A.
        • Freund G.C.
        • Gaeta J.M.
        • et al.
        Coronary artery reperfusion in acute myocardial infarction: Beneficial effects of intracoronary streptokinase on left ventricular salvage and performance.
        Am Heart J. 1981; 102: 1168
        • Reduto L.A.
        • Smalling R.W.
        • Greund G.C.
        • et al.
        Intra-coronary infusion of streptokinase in patients with acute myocardial infarction: Effects of reperfusion on left ventricular performance.
        Am J Cardiol. 1981; 48: 403
        • Reimer K.
        • Jennings R.
        The “wavefront phenomenon” of myocardial ischemic cell death: II. Transmural progression of necrosis within the framework of ischemic bed size and collateral flow.
        Lab Invest. 1979; 40: 633
        • Reimer K.
        • Lowe J.
        • Rasmussen M.
        • et al.
        The wavefront phenomenon of ischemic cell death.
        Circulation. 1977; 56: 786
        • Rentrop P.
        • Blanke H.
        • Kostering K.
        • et al.
        Acute myo-cardial infarction: Intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalization.
        Clin Cardiol. 1979; 5: 354
        • Rentrop P.
        • Feit F.
        • Blanke H.
        • et al.
        Effects of intra-coronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographie patterns and mortality in patients with acute myocardial infarction.
        N Engl J Med. 1984; 311: 1457
        • Ritchie J.L.
        • Davis K.B.
        • Williams D.L.
        • et al.
        Global and regional left ventricular function and tomographic radionuclide perfusion: The Western Washington intracoronary streptokinase in myocardial infarction trial.
        Circulation. 1984; 70: 867
        • Roan P.G.
        • Buja L.M.
        • Hashimi H.
        • et al.
        Interrelationship between regional left ventricular function, coronary blood flow, and myocellular necrosis during the initial 24 hours and one week after experimental coronary occlusion in awake, unsedated dogs.
        Circ Res. 1981; 49: 31
        • Roan P.G.
        • Scales F.
        • Saffer S.
        • et al.
        Functional characterization of left ventricular segment responses during the initial 24 hours and one week after experimental canine myocardial infarction.
        J Clin Invest. 1979; 63: 1074
        • Rogers W.J.
        • Mantle J.A.
        • Hood W.P.
        • et al.
        Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.
        Circulation. 1983; 68: 1051
        • Roubin G.S.
        • Robinson K.A.
        • King S.B.
        • et al.
        Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs.
        Circulation. 1987; 76: 891
        • Rovelli F.
        • DeVita C.
        • Feruglio G.A.
        • et al.
        The GISSI trial: Early results and late follow-up.
        J Am Coll Cardiol. 1987; 10: 33B
        • Santamore W.P.
        • Walensky P.
        Altered coronary flow re-sponses to vasoactive drugs in the presence of coronary arterial stenoses in the dog.
        Am J Cardiol. 1980; 45: 276
        • Schroder R.
        • Biamino G.
        • Leitner E.R.V.
        • et al.
        Intravenous short-term infusion of streptokinase in acute myocardial infarction.
        Circulation. 1983; 67: 536
        • Schroder R.
        • Neuhaus K.L.
        • Leizorovicz A.
        • et al.
        A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): Long-term mortality and morbidity.
        J Am Coll Cardiol. 1987; 9: 197
        • Schwartz J.S.
        • Carlyle P.F.
        • Cohn J.N.
        Effect of dilation of the distal coronary bed on flow and resistance in severely stenotic arteries in the dog.
        Am J Cardiol. 1979; 43: 219
        • Serur J.R.
        • Sinclair I.N.
        • Spokojny A.M.
        • et al.
        Laser balloon angioplasty (LBA): Effect on the carotid lumen in the dog.
        Circulation. 1985; 72: 111-457
        • Sheehan F.H.
        • Mathey D.G.
        • Schofer J.
        • et al.
        Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction.
        Circulation. 1985; 71: 1121
        • Sherman C.T.
        • Litvack F.
        • Grundfest W.
        • et al.
        Coronary angioscopy in patients with unstable angina pectoris.
        N Engl J Med. 1986; 315: 913
        • Sigwart U.
        • Puel J.
        • Mirkovitch V.
        • et al.
        Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.
        N Engl J Med. 1987; 316: 701
        • Simoons M.L.
        • Serruys P.W.
        • Brand M.
        • et al.
        Early throm-bolysis in acute myocardial infarction: Limitation of infarct size and improved survival.
        J Am Coll Cardiol. 1986; 7: 717
        • Simoons M.L.
        • Serruys P.W.
        • Brand M.
        • et al.
        Improved survival after early thrombolysis in acute myocardial infarction: A randomised trial by the Interuniversity Cardiology Institute in the Netherlands.
        Lancet. 1985; 2: 578
        • Simpson J.B.
        • Johnson D.E.
        • Thapliyal H.V.
        • et al.
        Transluminal atherectomy: A new approach to the treatment of atherosclerotic vascular disease.
        Circulation. 1985; 72: 111-146
        • Spann J.F.
        • Sherry S.
        • Carabella B.A.
        • et al.
        Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow-up studies.
        Am J Cardiol. 1984; 53: 655
        • Stack R.S.
        • Phillips H.
        • Guerson D.S.
        • et al.
        Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction.
        J Clin Invest. 1983; 72: 84
        • Tennant R.
        • Wiggers C.J.
        The effect of coronary occlusion on myocardial contraction.
        Am J Physiol. 1935; 112: 351
        • Theroux P.
        • Ross J.
        • Franklin D.
        • et al.
        Regional myocardial function early and later after myocardial infarction in the unanesthetized dog.
        Circ Res. 1977; 40: 158
        • TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) Trial: Phase I findings
        N Engl J Med. 1985; 312: 932
        • Topol E.J.
        • Califf R.M.
        • George B.S.
        • et al.
        A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.
        N Engl J Med. 1987; 317: 581
        • Topol E.J.
        • Califf R.M.
        • Kereiakes D.J.
        • et al.
        Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial.
        J Am Coll Cardiol. 1987; 10: 65B
        • Topol E.J.
        • Eha J.E.
        • Brin K.P.
        • et al.
        Applicability of percutaneous transluminal coronary angioplasty to patients with recombinant tissue plasminogen activator mediated thrombolysis.
        Cathet Cardiovasc Diagn. 1985; 11: 337
        • Topol E.J.
        • O’Neill W.W.
        • Langburd A.B.
        • et al.
        A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction.
        Circulation. 1987; 75: 420
        • Topol E.J.
        • Weiss J.L.
        • Brinker J.
        • et al.
        Regional wall motion improvement after nary thrombolysis with recombinant tissue plasminogen activator: Importance of coronary angiople.
        J Arg Coll Cardiol. 1985; 6: 426
        • Verstraete M.
        • Bernard R.
        Andomised trial of intravenous recoml jae-type plasminogen activator versus intra is streptokinase in acute myocardial infarction.
        Jancet. 1985; 1: 1-842
        • Vetrovec G.W.
        • Leinbach R.C.
        • Gold H.K.
        • et al.
        Intra-coronary thrombolysis in syndromes of unstable ischemia: Angiographic and clinical results.
        Am Heart J. 1982; 104: 946
        • Waller B.F.
        • Rothbaum D.A.
        • Pinkerton C.A.
        • et al.
        Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy.
        J Am Coll Cardiol. 1987; 9: 785
        • Williams D.O.
        • Borer J.
        • Braunwald E.
        • et al.
        Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: A report from the NHLBI thrombolysis in myocardial infarction trial.
        Circulation. 1986; 73: 338
        • Williams D.O.
        • Ruocco N.A.
        • Forman S.
        • et al.
        Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: A report from the Thrombolysis In Myocardial Infarction (TIMI) trial.
        J Am Coll Cardiol. 1987; 10: 45B
        • Wyatt H.L.
        • Forrester J.S.
        • Tyberg J.V.
        • et al.
        Effect of graded reductions in regional coronary perfusion on regional and total cardiac function.
        Am J Cardiol. 1975; 36: 185